Home » News from companies » The future of supplement innovation is clinically validated.

The future of supplement innovation is clinically validated.

This September, NXT USA is bringing its latest human clinical research to Vitafoods Asia — across four high-growth opportunities: digestive health, women’s hormonal health, healthy aging, and joint support.

Building your next science-backed product?

Meet with our team in Bangkok to discuss clinical data, formulation applications, and positioning opportunities across our portfolio.

What we’re bringing to Bangkok

Digexin®
Digestive comfort for the GLP-1 era, beginning in as little as 7 days.

BluNADBooster®

Plant-based NAD+ activation and preservation for healthy aging.

Xeya™ Modern Shatavari

Women’s hormonal health support at an effective dose of just 50–100 mg.

TamaFlex®

Fast-acting joint support with benefits beginning in just 5 days.

If you’re developing products in digestive health, women’s hormonal health, healthy aging, or joint mobility, let’s talk about the clinical data, formulation opportunities, and positioning behind our ingredients.

 

Schedule a Meeting at Vitafoods Asia

 

https://nxt-usa.com/

Trusted by

40 years connecting the world of science for industry

Our journals:

Login